Rankings / Longevity — Pharma (Off-Label)

Metformin

Longevity · Biguanide

Also known as: Glucophage ·Glumetza ·Fortamet ·Riomet

Tier B+

mtor-inhibitionampkmicrobiomebiguanideprescription
7.2 / 10
Tier B+
Ev 8 Bn 5 Sf 7

Bottom line

Read Off Label grades Metformin as B+ (7.2/10) based on strong evidence, variable benefit magnitude, and a low-med-risk safety profile.

UKPDS showed 36% reduction in all-cause mortality in T2D.

Typical use: 500-2000 mg/day PO; titrate from 500 mg with meals — Rx.

What this is

UKPDS showed 36% reduction in all-cause mortality in T2D. TAME trial ($75M, 3000 non-diabetic older adults) repeatedly delayed — FDA approved design but unfunded. 2019 Konopka data: may blunt exercise-induced mitochondrial adaptations.

Mechanism

Complex I mild inhibition → AMPK activation → mTOR inhibition; improved insulin sensitivity; possible gut microbiome effects; reduced hepatic gluconeogenesis

Dose & route

500-2000 mg/day PO; titrate from 500 mg with meals

Common questions

Does Metformin work?
Read Off Label rates the evidence for Metformin as Strong and the benefit magnitude as variable, producing an overall grade of B+ (7.2/10). UKPDS showed 36% reduction in all-cause mortality in T2D.
Is Metformin safe?
Metformin has a low-med risk profile in published human data. Legal status: Rx (off-label for longevity). This is not medical advice — see the disclaimer.
What is the typical dose for Metformin?
500-2000 mg/day PO; titrate from 500 mg with meals
How does Metformin work?
Complex I mild inhibition → AMPK activation → mTOR inhibition; improved insulin sensitivity; possible gut microbiome effects; reduced hepatic gluconeogenesis

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.